Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hydroxychloroquine for all patients with lupus nephritis: yes.
Pappa M, Boumpas DT, Fanouriakis A. Pappa M, et al. Among authors: boumpas dt. Nephrol Dial Transplant. 2024 Nov 27:gfae280. doi: 10.1093/ndt/gfae280. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39603834 No abstract available.
Investigating a middle‑step COVID‑19 unit in Greece.
Verykokou G, Papaioannou AI, Apollonatou V, Kavatha D, Boumpas D, Papiris SA, Manali ED, Loukides S. Verykokou G, et al. Among authors: boumpas d. Exp Ther Med. 2024 Nov 1;29(1):8. doi: 10.3892/etm.2024.12758. eCollection 2025 Jan. Exp Ther Med. 2024. PMID: 39563884 Free PMC article.
Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways.
Moysidou GS, Garantziotis P, Sentis G, Nikoleri D, Malissovas N, Nikoloudaki M, Stergioti EM, Polia S, Paschalidis N, Filia A, Grigoriou M, Nikolopoulos D, Kapsala N, Katechis S, Fanouriakis A, Bertsias G, Boumpas DT. Moysidou GS, et al. Among authors: boumpas dt. Ann Rheum Dis. 2024 Nov 13:ard-2024-226051. doi: 10.1136/ard-2024-226051. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39510807 Free article.
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study.
Pappa M, Kosmetatou M, Pieta A, Nikoloudaki M, Liapis NM, Tsalapaki C, Chalkia A, Argyriou E, Dimitroulas T, Cheila M, Demirtzoglou G, Papagoras C, Goules A, Katsiari C, Vassilopoulos D, Sidiropoulos P, Boki KA, Sfikakis PP, Liapis G, Gakiopoulou H, Voulgari PV, Boumpas DT, Bertsias G, Tektonidou MG, Fanouriakis A. Pappa M, et al. Among authors: boumpas dt. RMD Open. 2024 Sep 18;10(3):e004437. doi: 10.1136/rmdopen-2024-004437. RMD Open. 2024. PMID: 39299738 Free PMC article.
The NYMERIA Study: A Real-World, Multicentre Contemporary Assessment of Disease- and Patient-Related Burden and Treatment Strategies in Patients with Systemic Lupus Erythematosus.
Bertsias G, Fanouriakis A, Bartsakoulia M, Galanakis P, Boumpas DT. Bertsias G, et al. Among authors: boumpas dt. Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):392-401. doi: 10.31138/mjr.160524.tns. eCollection 2024 Jun. Mediterr J Rheumatol. 2024. PMID: 39193181 Free PMC article.
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study.
Gialouri CG, Chalkia A, Koutsianas C, Chavatza K, Argyriou E, Panagiotopoulos A, Karamanakos A, Dimouli A, Tsalapaki C, Thomas K, Orfanos P, Lagiou P, Katsikas G, Boki K, Boumpas D, Petras D, Vassilopoulos D. Gialouri CG, et al. Among authors: boumpas d. Rheumatology (Oxford). 2024 Aug 6:keae409. doi: 10.1093/rheumatology/keae409. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39107924
431 results